Cookie Consent
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
SCOPE is an international and independent full-service contract research organization (CRO) known as a reliable and trusted partner for many pharma, biotech and medical device companies. We have a great expertise in delivering clinical trials for development programs in the field of infectious diseases. One of our major USPs (unique selling point) is our close relationship with sites and a vast network of experts and key opinion leaders in the field.
Emphasized by the COVID-19-pandemic, infectious diseases with the potential to severely impact public health and economies have raised high interest for the development of new vaccines and cures. The need for clinical trial expert leadership is paramount to achieve fast bench-to-market timelines, especially when developing new drugs for unmet needs.
SCOPE provides this kind of expert leadership across the major market – EUROPE – that will make the difference for your clinical development programs and for the time to market, making new therapies available even faster for the benefit of public health and economies.
We work with in a network of fully operational local offices across Europe. Other areas are covered with well-established partners, all tailored to the need of your project and for the best performance of your trial.
Whether it’s a clinical developmental trial in phase I-III, post-authorization study in phase IV, study rescue, SCOPE has the expertise, know-how and resources to guide you through all phases of development while meeting your objectives and expectations.
SCOPE’s team has managed clinical trials (Phase I-IV) for:
SCOPE’s full-service portfolio offers you the whole set of fully integrated services while working with one dedicated Project Manager and the PM’s team. You will have the best team for the successful and efficient preparation and setup, submissions, conduct and close-out of your study.
COVID-19 has shown how dynamic the pandemic situation and the challenges for clinical research can be. With experience, flexibility and a pragmatic approach, SCOPE has established new, unique and regulatory sound processes to maintain recruitment in all clinical trials.
e.g. Arthritis-related Pain, Bladder Pain Syndrome, Cancer Pain, Chronic Pain, Headache / Migraine, Lower Back Pain, Neuropathic Pain (diabetic, postherpetic), Postoperative Pain Management, Rheumatic Pain, Acute Postoperative / Procedural Pain
e.g. ART (IVF, ICSI), Contraception, Endometriosis, Fibromyalgia Syndrome (FMS), Obstetrics, Oncology, Pain Management, PCOS, Polymyalgia Rheumatica, Postmenopausal Complaints, Preterm labor, Rheumatoid Arthritis, Vaginitis, Vulvar and Vaginal Atrophy, Vulvovaginal Candidiasis
e.g. Asthma (mild, moderate, severe, paediatric), Asthma / COPD Overlap Syndrome (ACOS), Chronic Obstructive Pulmonary Disease (COPD), Community-Acquired Pneumonia (CAP), Respiratory VirusInfection (including paediatric)
e.g. Alzheimer’s Disease, Bipolar Disorder, Depression, Epilepsy (including paediatric), Mania, Multiple Sclerosis, Narcolepsy, Parkinson’s Disease, Sensorineural Disorder
e.g. Community-acquired pneumonia (CAP), COVID-19, GI and Intra-Abdominal Infections, Immune-Modulator to prevent SARS-CoV Complication, Respiratory Virus Infections (including paediatric)
e.g. Cell and Gene Therapies, Early-Phase Clinical Development of ATMPs, Immunotherapy, Personalized Therapies, Regenerative Medicine
We support projects focusing on conditions such as hypertension, myocardial infarction, and pulmonary arterial hypertension – all high-impact topics in cardiovascular care and research.
Our experience spans across immune-related areas like allergies and vaccinations – key therapeutic fields with growing relevance.
We help communicate complex topics in metabolic disorders, including type 1 diabetes, where patient education and clarity are crucial.
From Non-Hodgkin lymphoma to various solid tumors – such as bladder, breast, colorectal, or prostate cancer – we bring clarity to oncology and hematology communication.
We develop content for dental indications such as periodontitis, caries prevention, oral mucositis, and temporomandibular disorders – always with precision and sensitivity.
We work on indications like alopecia areata, hypertrophic scars, and psoriasis – conditions that often impact both physical and emotional wellbeing.
Our projects cover topics such as diabetes, hormonal imbalances, and metabolic disorders – essential areas in endocrinology.
From Crohn’s disease and ulcerative colitis to irritable bowel syndrome and reflux – we translate complex GI conditions into clear communication.
We support education and awareness campaigns on hepatitis B and C, liver fibrosis, non-alcoholic fatty liver disease (NAFLD), and cirrhosis – all major topics in liver health.
Conditions like rheumatoid arthritis and polymyalgia rheumatica require nuanced and evidence-based communication – a strength we bring to every campaign.
Whether it’s conjunctivitis or retinopathy – we create accessible content for eye disorders aimed at both professionals and patients.
Rare diseases like idiopathic sudden sensorineural hearing loss demand tailored, precise messaging – we’re here to deliver just that.
We support communication around orthopedic topics such as cartilage defects and osteoarthritis – with a focus on clarity and empathy.
From sudden hearing loss and rhinitis to rare conditions like Schwannomas – we bring ENT topics to life with targeted messaging.
We cover a range of urological topics – from bladder and prostate cancer to bladder pain syndrome and kidney cancer – always with scientific accuracy and approachability.
Our work includes vaccine communication for Hepatitis B, influenza, rabies, and tuberculosis – complex topics made clear and compliant.
